STIM - Neuronetics, Inc Trailing Twelve Months Revenue Growth

Neuronetics, Inc. (STIM) management's competence in defending market share and the transparency of TMS metrics have ensured business resilience. Year-over-year sales dynamics over the last four quarters visualize the current status, where 22.90 serves as the current parameter value. This allows the team to scale the clinic network, expand insurance reimbursements, and introduce equipment to global markets to combat depression.
neurostar.com (STIM) - metric breakdowns and financial figures

This indicator measures the daily rolling revenue growth over the last 12 months, reflecting the fundamental quality of management and current demand for the company's products. By analyzing the TTM annual sales growth on the GURU.Markets platform, an investor assesses the scaling efficiency of Neuronetics, Inc. (STIM), where stable sales dynamics confirm the reliability of the logistics chains delivering high-tech brain stimulation equipment to clinics.